Disequilibrium of M1 and M2 Macrophages Correlates with the Development of Experimental Inflammatory Bowel Diseases

References

• Atochina O, Daly-Engel T, Piskorska D, et al. (2001). A schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Gr-1+ macrophages that suppress naïve CD4+ T cell proliferation via an IFN-γ and nitric oxide-dependent mechanism. J Immunol, 167, 4293–302
   PubMedGoogle Scholar
• Bogdan C, Paik J, Vodovotz Y, Nathan C. (1992). Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem, 267, 23301–8
   PubMed Web of Science ®Google Scholar
• Cooper HS, Murthy SN, Shah RS, Sedergran DJ. (1993). Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest, 69, 238–49
   PubMed Web of Science ®Google Scholar
• Danese S, Fiocchi C. (2011). Ulcerative colitis. N Engl J Med, 365, 1713–25
   PubMed Web of Science ®Google Scholar
• Denning TL, Wang YC, Patel SR, et al. (2007). Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol, 8, 1086–94
   PubMed Web of Science ®Google Scholar
• Elson CO, Cong Y, Weaver CT, et al. (2007). Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology, 132, 2359–70
   PubMed Web of Science ®Google Scholar
• Engelhardt B, Martin-Simonet MT, Rott LS, et al. (1998). Adhesion molecule phenotype of T lymphocytes in inflamed CNS. J Neuroimmunol, 84, 92–104
   PubMedGoogle Scholar
• Fox JG, Beck P, Dangler CA, et al. (2000). Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces Helicobacter-induced gastric atrophy. Nat Med, 6, 536–42
   PubMed Web of Science ®Google Scholar
• Galli SJ, Borregaard N, Wynn TA. (2011). Phenotypic and functional plasticity of cells of innate immunity: Macrophages, mast cells and neutrophils. Nat Immunol, 12, 1035–44
   PubMed Web of Science ®Google Scholar
• Gordon S. (2003). Alternative activation of macrophages. Nat Rev Immunol, 3, 23–35
   PubMed Web of Science ®Google Scholar
• Gordon S, Martinez FO. (2010). Alternative activation of macrophages: Mechanism and functions. Immunity, 32, 593–604
   PubMed Web of Science ®Google Scholar
• Gordon S, Taylor PR. (2005). Monocyte and macrophage heterogeneity. Nat Rev Immunol, 5, 953–64
   PubMed Web of Science ®Google Scholar
• Hue S, Ahern P, Buonocore S, et al. (2006). Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med, 203, 2473–83
   PubMed Web of Science ®Google Scholar
• Hunter MM, Wang A, Hirota CL, McKay DM. (2005). Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis. J Immunol, 174, 7368–75
   PubMedGoogle Scholar
• Hunter MM, Wang A, Parhar KS, et al. (2010). In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology, 138, 1395–405
   PubMed Web of Science ®Google Scholar
• Jang SW, Cho MK, Park MK, et al. (2011). Parasitic helminth cystatin inhibits DSS-induced intestinal inflammation via IL-10(+)F4/80(+) macrophage recruitment. Kor J Parasitol, 49, 245–54
   PubMedGoogle Scholar
• Leung NE, Mabarrack N, Barbour A, et al. (2010). Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol, 30, 80–9
   PubMedGoogle Scholar
• Mahida YR. (2000). The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis, 6, 21–33
   PubMed Web of Science ®Google Scholar
• Mantovani A, Locati M. (2009). Orchestration of macrophage polarization. Blood, 114, 3135–6
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Locati M. (2005). Macrophage polarization comes of age. Immunity, 23, 344–6
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Locati M. (2007). New vistas on macrophage differentiation and activation. Eur J Immunol, 37, 14–16
   PubMed Web of Science ®Google Scholar
• Mosser DM, Edwards JP. (2008). Exploring the full spectrum of macrophage activation. Nat Rev Immunol, 8, 958–69
   PubMed Web of Science ®Google Scholar
• Murai M, Turovskaya O, Kim G, et al. (2009). Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol, 10, 1178–84
   PubMed Web of Science ®Google Scholar
• Ordás I, Eckmann L, Talamini M, et al. (2012). Ulcerative colitis. Lancet, 380, 1606–19
   PubMed Web of Science ®Google Scholar
• Pastorelli L, Garg RR, Hoang SB, et al. (2010). Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. PNAS, 107, 8017–22
   PubMed Web of Science ®Google Scholar
• Rogler G. (2004). Update in inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol, 20, 311–17
   PubMed Web of Science ®Google Scholar
• Sica A, Bronte V. (2007). Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest, 117, 1155–66
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang YP, Zheng G, et al. (2007). Ex vivo programmed macro-phages ameliorate experimental chronic inflammatory renal dis-ease. Kidney Int, 72, 290–9
   PubMed Web of Science ®Google Scholar
• Watanabe T, Kitani A, Murray PJ, Strober W. (2004). NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol, 5, 800–8
   PubMed Web of Science ®Google Scholar
• Xavier RJ & Podolsky DK. (2007). Unravelling the pathogenesis of inflammatory bowel disease. Nature, 448, 427–34
   PubMed Web of Science ®Google Scholar
• Xing Q, Su H, Cui J, Wang B. (2012). Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: A possible relation with lupus nephritis. Immunol Invest, 41, 15–27
   PubMed Web of Science ®Google Scholar
• Yen D, Cheung J, Scheerens H, et al. (2006). IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest, 116, 1310–16
   PubMed Web of Science ®Google Scholar